Suppression of tumor cell invasiveness and in vivo tumor growth by microRNA-874 in non-small cell lung cancer

Biochemical and Biophysical Research Communications

Volumn 434, Issue 3, 2013, Pages 627-633

  Kesanakurti, Divya ^a   Maddirela, Dilip Rajasekhar ^a   Chittivelu, Subramanyam ^a   Rao, Jasti S ^a   Chetty, Chandramu ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

CSC; Invasion; Lung cancer; MicroRNA; miR 874; NSCLC

Indexed keywords

ANTINEOPLASTIC AGENT; CD133 ANTIGEN; GELATINASE A; MICRORNA; MICRORNA 874; UNCLASSIFIED DRUG; UROKINASE; MIRN874 MICRORNA, HUMAN; PRIMER DNA;

A549 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER STEM CELL; CANCER TISSUE; CELL DIFFERENTIATION; CELL MIGRATION; CELL POPULATION; COMPUTER MODEL; CONTROLLED STUDY; EPITHELIOID CELL; H1299 CELL LINE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER CELL LINE; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; TUMOR INVASION; CELL DIVISION; GENETICS; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

MUS; MUS MUSCULUS;

BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MLCS; MLOWN;

EID: 84880450812     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.132     Document Type: Article

References (37)

1. A. Jemal, J. Ma, P.S. Rosenberg, R. Siegel, W.F. Anderson, Increasing lung cancer death rates among young women in southern and midwestern states, J. Clin. Oncol. 30 (2012) 2739-2744.
2. M. Bacac, I. Stamenkovic, Metastatic cancer cell, Annu. Rev. Pathol. 3 (2008) 221-247, http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.151523.
3. M. Egeblad, Z. Werb, New functions for the matrix metalloproteinases in cancer progression, Nat. Rev. Cancer 2 (2002) 161-174.
4. J.S. Rao, Molecular mechanisms of glioma invasiveness: the role of proteases, Nat. Rev. Cancer 3 (2003) 489-501.
5. L.E. Ailles, I.L. Weissman, Cancer stem cells in solid tumors, Curr. Opin. Biotechnol. 18 (2007) 460-466.
6. J.E. Visvader, G.J. Lindeman, Cancer stem cells in solid tumours: accumulating evidence and unresolved questions, Nat. Rev. Cancer 8 (2008) 755-768.
7. A. Esquela-Kerscher, F.J. Slack, Oncomirs-microRNAs with a role in cancer, Nat. Rev. Cancer 6 (2006) 259-269.
8. W. Filipowicz, S.N. Bhattacharyya, N. Sonenberg, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?, Nat Rev. Genet. 9 (2008) 102-114.
9. Y. Hiyoshi, H. Kamohara, R. Karashima, N. Sato, Y. Imamura, Y. Nagai, N. Yoshida, E. Toyama, N. Hayashi, M. Watanabe, H. Baba, MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma, Clin. Cancer Res. 15 (2009) 1915-1922.
10. A. Markou, E.G. Tsaroucha, L. Kaklamanis, M. Fotinou, V. Georgoulias, E.S. Lianidou, Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RTPCR, Clin. Chem. 54 (2008) 1696-1704.
11. A. Markou, Y. Liang, E. Lianidou, Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer, Clin. Chem. Lab. Med. 49 (2011) 1591-1603.
12. N. Nohata, T. Hanazawa, N. Kikkawa, D. Sakurai, L. Fujimura, T. Chiyomaru, K. Kawakami, H. Yoshino, H. Enokida, M. Nakagawa, A. Katayama, Y. Harabuchi, Y. Okamoto, N. Seki, Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma, Br. J. Cancer 105 (2011) 833-841.
13. A. Eramo, F. Lotti, G. Sette, E. Pilozzi, M. Biffoni, V.A. Di, C. Conticello, L. Ruco, C. Peschle, M.R. De, Identification and expansion of the tumorigenic lung cancer stem cell population, Cell Death Differ. 15 (2008) 504-514.
14. S. Griffiths-Jones, The microRNA registry, Nucleic Acids Res. 32 (2004) D109-D111.
15. D. Kesanakurti, C. Chetty, D.H. Dinh, M. Gujrati, J.S. Rao, Role of MMP-2 in the regulation of IL-6/Stat3 survival signaling via interaction with alpha5beta1 integrin in glioma, Oncogene 32 (2013) 327-340.
16. D. Kesanakurti, C. Chetty, P. Bhoopathi, S.S. Lakka, B. Gorantla, A.J. Tsung, J.S. Rao, Suppression of MMP-2 attenuates TNF-alpha induced NF-kappaB activation and leads to JNK mediated cell death in glioma, PLoS One 6 (2011) e19341.
17. C.S. Gondi, S.S. Lakka, N. Yanamandra, K. Siddique, D.H. Dinh, W.C. Olivero, M. Gujrati, J.S. Rao, Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis, Oncogene 22 (2003) 5967-5975.
18. C. Chetty, P. Bhoopathi, P. Joseph, S. Chittivelu, J.S. Rao, S.S. Lakka, Adenovirus-mediated siRNA against MMP-2 suppresses tumor growth and lung metastasis in mice, Mol. Cancer Ther. 5 (2006) 2289-2299.
19. V.K. Rajasekhar, L. Studer, W. Gerald, N.D. Socci, H.I. Scher, Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappaB signalling, Nat. Commun. 2 (2011) 162.
20. W.P. Kloosterman, E. Wienholds, B.E. de, S. Kauppinen, R.H. Plasterk, Nat. Methods 3 (2006) 27-29.
21. A.S. Boehle, P. Dohrmann, I. Leuschner, H. Kalthoff, D. Henne-Bruns, An improved orthotopic xenotransplant procedure for human lung cancer in SCID bg mice, Ann. Thorac. Surg. 69 (2000) 1010-1015.
22. C.T. Jordan, M.L. Guzman, M. Noble, Cancer stem cells, N. Engl. J. Med. 355 (2006) 1253-1261.
23. J. Hillion, L.J. Wood, M. Mukherjee, R. Bhattacharya, C.F. Di, J. Kowalski, O. Elbahloul, J. Segal, J. Poirier, C.M. Rudin, S. Dhara, A. Belton, B. Joseph, S. Zucker, L.M. Resar, Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer, Mol. Cancer Res. 7 (2009) 1803-1812.
24. Q. Qian, Q. Wang, P. Zhan, L. Peng, S.Z. Wei, Y. Shi, Y. Song, The role of matrix metalloproteinase 2 on the survival of patients with non-small cell lung cancer: a systematic review with meta-analysis, Cancer Invest. 28 (2010) 661-669.
25. R. Roy, J. Yang, M.A. Moses, Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer, J. Clin. Oncol. 27 (2009) 5287-5297.
26. K. Dass, A. Ahmad, A.S. Azmi, S.H. Sarkar, F.H. Sarkar, Evolving role of uPA/uPAR system in human cancers, Cancer Treat. Rev. 34 (2008) 122-136.
27. M.V. Carriero, P. Franco, G. Votta, I. Longanesi-Cattani, M.T. Vento, M.T. Masucci, A. Mancini, M. Caputi, I. Iaccarino, M.P. Stoppelli, Regulation of cell migration and invasion by specific modules of uPA: mechanistic insights and specific inhibitors, Curr. Drug Targets 12 (2011) 1761-1771.
28. C.H. Tang, M.L. Hill, A.N. Brumwell, H.A. Chapman, Y. Wei, Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with beta1 integrins, J. Cell Sci. 121 (2008) 3747-3756.
29. S. Baranwal, S.K. Alahari, MiRNA control of tumor cell invasion and metastasis, Int. J. Cancer 126 (2010) 1283-1290.
30. A. Aigner, MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs, J. Mol. Med. (Berl.). 89 (2011) 445-457.
31. G.T. Bommer, I. Gerin, Y. Feng, A.J. Kaczorowski, R. Kuick, R.E. Love, Y. Zhai, T.J. Giordano, Z.S. Qin, B.B. Moore, O.A. MacDougald, K.R. Cho, E.R. Fearon, P53-mediated activation of miRNA34 candidate tumor-suppressor genes, Curr. Biol. 17 (2007) 1298-1307.
32. J. Takamizawa, H. Konishi, K. Yanagisawa, S. Tomida, H. Osada, H. Endoh, T. Harano, Y. Yatabe, M. Nagino, Y. Nimura, T. Mitsudomi, T. Takahashi, Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival, Cancer Res. 64 (2004) 3753-3756.
33. N. Yanaihara, N. Caplen, E. Bowman, M. Seike, K. Kumamoto, M. Yi, R.M. Stephens, A. Okamoto, J. Yokota, T. Tanaka, G.A. Calin, C.G. Liu, C.M. Croce, C.C. Harris, Unique microRNA molecular profiles in lung cancer diagnosis and prognosis, Cancer Cell 9 (2006) 189-198.
34. A. Lagana, F. Russo, C. Sismeiro, R. Giugno, A. Pulvirenti, A. Ferro, Variability in the incidence of miRNAs and genes in fragile sites and the role of repeats and CpG islands in the distribution of genetic material, PLoS One 5 (2010) e11166.
35. A.F. Fundia, N.B. Gorla, M.M. Bonduel, O. Azpilicueta, H. Lejarraga, F.S. Muriel, I.B. Larripa, Increased expression of 5q31 fragile site in a Bloom syndrome family, Hum. Genet. 89 (1992) 569-572.
36. E.C. Thorland, S.L. Myers, B.S. Gostout, D.I. Smith, Common fragile sites are preferential targets for HPV16 integrations in cervical tumors, Oncogene 22 (2003) 1225-1237.
37. J. Wang, Y. Cai, Matrix metalloproteinase 2 polymorphisms and expression in lung cancer: a meta-analysis, Tumour Biol. 33 (2012) 1819-1828.